Genesis Healthcare, Inc. Stock Deutsche Boerse AG
Equities
SH11
US37185X1063
Healthcare Facilities & Services
Sales 2021 * | 3.46B 3.23B 4.73B | Sales 2022 * | - | Capitalization | 134K 125K 183K |
---|---|---|---|---|---|
Net income 2021 * | -22M -20.54M -30.09M | Net income 2022 * | - | EV / Sales 2021 * | 0.95 x |
Net Debt 2021 * | 3.28B 3.06B 4.48B | Net cash position 2022 * | - 0 0 | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-0.01
x | P/E ratio 2022 * |
-
| Employees | 44,000 |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 46.99% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | 21-01-31 | |
Public Communications Contact | - | - | |
Susan Overton
LAW | General Counsel | - | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 15-02-01 | |
John Randazzo
BRD | Director/Board Member | 69 | 21-03-01 |
Chairman | 79 | 21-03-01 |
1st Jan change | Capi. | |
---|---|---|
+18.69% | 84.15B | |
-25.20% | 74.14B | |
+1.62% | 26.92B | |
-10.46% | 17.15B | |
-0.68% | 16.83B | |
-0.73% | 15.21B | |
+72.88% | 13.3B | |
+76.04% | 12.99B | |
-25.79% | 12.79B |